HTTP://WWW.ABINGWORTH.COM LONDON, X0 Investment Advisor How do I update this listing?

Abingworth LLP is based out of London. Abingworth LLP is a registered investment advisory firm with discretionary assets under management (AUM) of $0 (Form ADV from 2015-02-25). Their last reported 13F filing for Q4 2020 included $292,327,000 in managed 13F securities and a top 10 holdings concentration of 98.38%. Abingworth LLP's largest holding is Vaxcyte, Inc. with shares held of 4,168,718. Whalewisdom has at least 42 13F filings, 41 13D filings, 21 13G filings, and 17 Form 4 filings

Download 13F Summary Create Alert


13F Activity

  • Market Value $292.327 Million
  • Prior Market Value $467.504 Million
  • New Purchases1 stock
  • Additional Purchases0 stocks
  • Sold out of3 stocks
  • Reduced holdings in1 stock
  • Top 10 Holdings % 98.38 %
  • Turnover % [1]:26.67%
  • Turnover Alt % [2]: 14.73 %
  • Time Held Top20:10.00 quarters
  • Time Held Top10:5.60 quarters
  • Time Held All:10.00 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.


13F Sector Allocation Over Time

Portfolio Performance

Top 20 equal-weighted holdings. Performance numbers calculated through 2020-11-16

Performance for Q3 2020: 6.58%
Performance Last 4 Quarters: 38.84%
Performance Metrics
Stats are not available for the latest quarter

Refresh Advanced Export Download CSV Download Excel (.xlsx) Download TSV
Filter by:

Security Types:

*Shares are split adjusted

View Last Form Adv Compilation Report on Record


Business Phone: +44 207 534 1500
Fax: +44 207 534 1539
Professional Investment Advisor Data
SEC Registration as :
Form of Organization: Limited Liability Partnership
Organized in:
Number of employees:
Other Business Activities:
Advisor Fees/Compensation:
Amount of client funds and securities:
Total Number of Clients: 0
Amount of client funds and securities by related persons:
Total Number of clients from related persons:
Data above was derived from SEC filings.

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year


WhaleScore history for ABINGWORTH LLP

You must have a subscription to view WhaleScore histories

**EXPERIMENTAL** Current UK Positions

Updated daily

Contains transactions from January 1st, 2015 on.

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
ABINGWORTH LLP Verona Pharma plc 2017-05-03 7,215,553 7.29%
ABINGWORTH LLP Sinclair Pharma plc 2016-09-30 29,674,270 5.91%
ABINGWORTH LLP ReNeuron Group plc 2015-08-25 83,652,000 2.65%

Position History

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
ABINGWORTH LLP Verona Pharma plc 2016-07-29 175,527,671 6.84%

Elevate your investments